Corcept Therapeutics | CORT - Operating Expenses

Stock Price
40.71
Daily Change
0.84 2.11%
Monthly
16.48%
Yearly
-38.83%
Q1 Forecast
38.64

Corcept Therapeutics reported $197.42M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Acadia Pharmaceuticals USD 242.88M 10.68M Sep/2025
Alaunos Therapeutics USD 1.19M 428K Sep/2025
ANI Pharmaceuticals USD 505.82M 309.62M Sep/2025
Ardelyx USD 105.66M 6.4M Sep/2025
Aurora Cannabis CAD 146.03M 27.79M Sep/2025
BioMarin Pharmaceutical USD 807.82M 259.3M Sep/2025
Bristol-Myers Squibb USD 18.55B 10.06B Sep/2025
Canopy Growth CAD 80.99M 8.64M Sep/2025
Corcept Therapeutics USD 197.42M 29.66M Sep/2025
Eli Lilly USD 9.21B 677.8M Sep/2025
J&J USD 18.97B 2.38B Dec/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Merck USD 10.72B 1.28B Sep/2025
Novartis USD 9.86B 115M Sep/2025
Novartis USD 9.77B 401M Sep/2025
Pacira USD 166.36M 4.5M Sep/2025
Pfizer USD 92.8B 82.47B Sep/2025
Supernus Pharmaceuticals USD 252.29M 98.98M Sep/2025
TG Therapeutics USD 132.34M 26.04M Sep/2025